David Sarpong

Background

About David Sarpong

I am Professor of Strategy and Organisation, and Director of Research of the Marketing and Strategy Subject Group at Aston Business School. Before joining Aston, I was Professor of Strategic Management at Brunel University London, where I also served as Head of the Strategy, Entrepreneurship, and International Business (SEIB) Research Group. I Previously held the position of Division Lead of the Strategy, Entrepreneurship, and International Business Subject Group at Brunel, Senior lecturer in Strategy and Course Director at UWE Bristol, Visiting Senior Research Fellow at the Higher School of Economics (HSE) Laboratory for Economics of Innovation, and an Honorary Research Fellow at the School of Management, Information Technology, and Public Governance, University of Kwazulu-Natal, South Africa. Externally, I am the elected UK Country Representative (2024-2027) for the European Academy of Management (EURAM), and a Member of the International Committee of the Chartered Association of Business Schools (CABS), where I am working with colleagues to identifying and exploring novel strategies for the academy to tackle the biggest issues facing the internationalisation of business schools, both in the UK and abroad. A former Convener of the annual Doctoral Symposium of the Academy, and an elected Vice Chair of the British Academy of Management (BAM), I serve on the BAM Council's Academic Affairs of Conference and Capacity Building (AACCB) sub-Committee. In terms of scholarship, I am the Editor-in-Chief for the Journal of Strategy and Leadership (S&L), Associate Editor of Business Strategy and the Environment (BSE), and Senior Associate Editor for the European Management Journal (EMJ). I currently enjoy a Visiting Professorship at the Bristol Business School, an Adjunct Visiting Professorship at the KNUST Business School, and Trustee and Board Membership at The Milestones Trust, a social care charity based in Bristol that supports adults with learning disabilities and mental health issues, and people with complex cases of dementia.